Inhaler and nebulizer administration: a guide for nursing students

Inhaled medications are the cornerstone of treatment for asthma, COPD, cystic fibrosis, and a range of other respiratory conditions. Getting the drug into the lungs — not the mouth, the oropharynx, or the air — depends almost entirely on technique. A patient who uses an inhaler incorrectly may receive as little as 10–20% of the labeled dose, while a patient using correct technique with a spacer can deposit 20–40% of the dose in the lower airways. The device type matters, the patient’s coordination matters, and the nurse’s ability to teach and correct technique matters.

This guide covers every inhaler and nebulizer delivery system tested on NCLEX: metered-dose inhalers (MDI), dry powder inhalers (DPI), soft-mist inhalers (SMI), and nebulizers. It includes step-by-step technique tables, a device comparison table, peak flow action zones, a common-errors correction table, and a 15-point NCLEX tip bank.

For the disease contexts in which these devices are most commonly used, see the asthma nursing guide and the COPD nursing guide. For the broader respiratory drug delivery context, including supplemental oxygen, see the oxygen therapy nursing guide.

Device overview: MDI, DPI, nebulizer, and SMI

The four main categories of inhaled medication delivery differ in how the drug is prepared, how the patient inhales, whether coordination is required, and which patient populations they best serve. Understanding these differences is the foundation of device selection, patient teaching, and NCLEX success.

MDI technique: with and without a spacer

The metered-dose inhaler is the most widely prescribed inhaler in the United States, and also the most frequently used incorrectly. The key error is pressing the canister before beginning to inhale — or inhaling too fast — so the drug impacts the back of the throat rather than traveling into the airways. A spacer eliminates the coordination problem and increases pulmonary deposition significantly.

Spacer/valved holding chamber: who needs it?

A spacer — also called a valved holding chamber (VHC) — holds the cloud of medication between the inhaler and the patient’s mouth, allowing a slower, more deliberate inhalation. The one-way valve prevents exhaled air from re-entering the chamber.

The spacer is required (not optional) for:

• Inhaled corticosteroids (ICS) — reduces oropharyngeal deposition, lowers candidiasis risk
• Children under 5 (use face mask attachment; children 5 years and older can typically use a mouthpiece)
• Patients with poor hand-breath coordination (stroke, Parkinson’s disease, severe arthritis)
• During acute exacerbations when coordination is impaired by dyspnea

Spacer cleaning (weekly): Remove the MDI canister. Wash chamber and mouthpiece in mild soap and warm water. Allow to air dry — do not rub dry with a cloth, as static can reduce drug delivery. Reassemble when completely dry.

DPI technique

Dry powder inhalers work on fundamentally different physics than MDIs: there is no propellant, and the powder is drawn from the device by the patient’s own inspiratory effort. This means:

1. Shaking is not only unnecessary — it is harmful. Shaking a loaded DPI can disperse the powder and reduce the available dose. Some devices have pre-loaded blisters; others require loading per dose.
2. A spacer cannot be used. A spacer traps the dry powder and prevents it from reaching the airways.
3. Inhalation must be fast and forceful. The opposite of MDI technique. A slow gentle breath is insufficient to disaggregate the powder particles and carry them into the lower airways.
4. Patients must exhale before use — but not into the device. Exhaling into the DPI mouthpiece can introduce moisture, which clumps the powder and renders the dose ineffective.

DPI technique steps:

1. Load the dose per device instructions (rotate disk, twist base, press button — varies by device).
2. Exhale fully — away from the device mouthpiece.
3. Seal lips tightly around the mouthpiece.
4. Inhale as fast and as deeply as possible (forceful, quick inspiration).
5. Hold breath for 5–10 seconds.
6. Exhale — away from the device, never back into the mouthpiece.
7. If a second dose is needed, repeat loading and inhalation steps.

DPI in acute exacerbations: A limitation of DPIs in clinical emergencies — if the patient is too breathless to generate adequate inspiratory flow (typically greater than 30–60 L/min depending on the device), the dose will not disaggregate properly. In severe bronchospasm, switch to a nebulizer or MDI with spacer.

Soft-mist inhaler (Respimat) technique

The soft-mist inhaler uses a spring-driven aqueous mechanism to produce a slow-moving mist that travels over approximately 1.5 seconds — much slower than MDI aerosol. This slow delivery gives the patient more time to inhale completely and reduces oropharyngeal deposition.

Priming (first use and after not using for more than 21 days):

1. Turn the base in the direction of the arrows until it clicks (half turn).
2. Open the cap, point toward the floor, press the dose-release button, repeat 3 more times until a fine mist appears (4 actuations total).

Technique:

1. Hold upright, turn base until it clicks.
2. Open cap. Exhale fully — away from mouthpiece.
3. Seal lips around mouthpiece.
4. Begin inhaling slowly and deeply, then press the dose-release button while continuing to inhale.
5. Hold breath for 10 seconds.
6. Close cap.

Note: unlike the MDI, the SMI does not require shaking — the aqueous solution is uniform. Unlike the DPI, inhalation should be slow and deep.

Nebulizer technique

A nebulizer converts a liquid medication into a fine aerosol mist using compressed air (jet nebulizer) or ultrasonic vibration (ultrasonic nebulizer). Nebulizers do not require coordination, specific inspiratory flow, or breath-holding, making them the preferred option for infants, young children, acute exacerbations with severe dyspnea, and patients on mechanical ventilation.

Mouthpiece vs mask:

• Mouthpiece is preferred for adults. A mouthpiece delivers more medication to the lower airways than a face mask, because a mask deposits a significant portion of the aerosol on the face and in the upper nasal passages.
• Mask is used for infants, toddlers, and patients who cannot hold a mouthpiece (obtunded, fatigued, or developmentally unable to cooperate).
• If a mask must be used in a cooperative adult: hold it tightly against the face and breathe through the mouth, not the nose.

Nebulizer setup and technique:

1. Wash hands. Assemble the nebulizer cup, tubing, and mouthpiece (or mask).
2. Add the prescribed medication volume to the nebulizer cup (typically 3–5 mL total volume; if the ordered volume is less, dilute with normal saline to 3–5 mL to ensure adequate nebulization time).
3. Connect tubing to the compressor or compressed air source.
4. Have the patient sit upright (90 degrees or as upright as possible) — upright posture optimizes tidal volume and aerosol deposition.
5. Turn on compressor. Mist should appear within a few seconds.
6. Patient breathes normally through the mouthpiece or mask — normal tidal breathing, no special technique needed.
7. Typical treatment time: 10–15 minutes (until the cup sputters, indicating medication is exhausted).
8. Occasional tapping of the nebulizer cup during treatment dislodges droplets from the sides and increases delivered dose.
9. After treatment, wash nebulizer cup and mouthpiece with soap and water; allow to air dry. Rinse the cup with sterile or distilled water — tap water can introduce pathogens.

Continuous bronchodilator nebulization: In severe acute asthma, albuterol can be given as a continuous nebulization rather than intermittent treatments. This is an ICU or emergency department intervention requiring close monitoring of heart rate, blood pressure, and electrolytes (particularly potassium — beta-agonist stimulation causes potassium shift into cells).

Bronchodilator before corticosteroid: sequence matters

When a patient uses both a bronchodilator and an inhaled corticosteroid (ICS), sequence matters clinically:

Always give the bronchodilator first.

Short-acting beta-agonist (SABA) or short-acting muscarinic antagonist (SAMA) is administered first, allowing bronchodilation to occur over 5–15 minutes. When the airways have widened, the subsequent ICS dose can penetrate deeper into the smaller airways and achieve greater mucosal deposition. Giving the ICS first — into constricted airways — limits its distribution.

This principle applies to both inhalers and nebulizers. If a patient’s nebulizer treatment includes both albuterol (SABA) and budesonide (ICS), administer albuterol first; then administer budesonide after bronchodilation has been established.

For medication classification of bronchodilators and corticosteroids, see the drug classifications nursing guide.

Respiratory drug classes: clinical overview

Understanding the drug classes helps nurses anticipate which device is most likely to be prescribed and how to counsel the patient.

LABA used as monotherapy in asthma is contraindicated — this is a high-yield NCLEX concept. LABAs must always be combined with an ICS in asthma management. For CF-specific nebulized agents including dornase alfa and hypertonic saline, see the cystic fibrosis nursing guide.

Peak flow monitoring

A peak flow meter measures peak expiratory flow rate (PEFR) — the fastest speed at which air can be forcefully exhaled after a maximum inhalation. In asthma management, PEFR is used to assess disease control, guide medication adjustments, and identify deterioration before symptoms become severe.

How to measure peak flow:

1. Attach the peak flow meter to the mouthpiece. Set marker to zero.
2. Patient stands (if able) or sits upright.
3. Patient inhales as deeply as possible.
4. Patient seals lips around mouthpiece and exhales as hard and fast as possible — a single short, sharp blast.
5. Record the number. Repeat two more times. Record the highest of three readings.
6. Compare to personal best.

Personal best: Established during a period of good control — typically the highest PEFR consistently achieved over a 2–3 week period. The personal best is used as the 100% reference point for zone calculations, because normal predicted values can underestimate an individual’s capacity.

Peak flow and SABA overuse: If a patient is using their rescue inhaler (SABA) for symptoms more than two days per week (excluding pre-exercise use), this is an indicator of poor asthma control — not a sign that the inhaler is working well. Escalation of controller therapy should be discussed with the provider. Chronic SABA overuse carries risk: in asthma, reliance on SABA without adequate ICS is associated with increased exacerbation and mortality risk. Document SABA usage frequency and report patterns of overuse.

How to identify an empty MDI

Knowing when an MDI canister is empty is clinically significant — a patient who thinks they are receiving their medication but is using an empty inhaler can deteriorate rapidly without realizing the cause.

Dose counter (preferred): Most modern MDI canisters have a built-in dose counter that increments with each actuation. When the counter reaches zero, the canister is empty. Advise patients to track the counter and reorder before it reaches the last 20–30 doses.

Weight (backup method): A full canister weighs more than an empty canister. Patients can weigh the canister over time to track depletion, though this is less reliable than a dose counter.

Float test (outdated — not recommended): Historically, patients were taught to place the canister in a bowl of water: a canister that floats on its side is empty, one that sinks is full. This method is no longer recommended for most modern MDIs because water can enter the valve mechanism, damage the canister, and affect drug delivery. Do not teach the float test for current MDI devices unless specifically directed by the manufacturer.

Running out mid-dose: Patients sometimes continue actuating an empty canister because they can still hear a sound or feel a sensation. Reinforce dose counter checking and prescription refill timing.

Inhaler storage and priming

Storage:

• Store MDIs at room temperature — avoid freezing, prolonged heat, and exposure to temperatures above 120°F (stored in glove compartments in summer, for example). Cold temperatures reduce propellant pressure and result in smaller delivered dose.
• Store DPIs away from humidity — moisture clumps the dry powder and ruins the dose. Never leave a DPI in a humid bathroom.
• Store with the mouthpiece cap on to prevent debris from entering.

Priming:

• New MDI or MDI unused for more than 2 weeks: Prime by shaking and releasing 2–4 test actuations into the air (not into the patient). The number varies by device — consult the package insert.
• New SMI: Prime as described above — 4 actuations until mist appears.
• DPI devices: Priming varies by device. Many DPIs (e.g., Diskus) do not require priming in the same way because the dose is loaded immediately before use.

Patient education: common errors and corrections

Teaching inhaler technique is a core nursing responsibility. Studies consistently show that the majority of patients — across all ages and education levels — demonstrate at least one significant technique error. The table below covers the most NCLEX-tested errors.

Special populations

Pediatric patients

Device selection in children is age-dependent:

• Infants and toddlers (0–3 years): MDI with spacer and attached face mask. The child breathes normally; the nurse or caregiver actuates the inhaler. Ensure a tight face seal — a gap around the mask significantly reduces delivered dose.
• Children 4–6 years: MDI with spacer and mouthpiece, transitioning from mask. Child must be coached to seal lips around the mouthpiece and inhale slowly.
• Children 7 years and older: Can generally use MDI with spacer and mouthpiece independently with training. Some older children can manage a DPI; this requires adequate inspiratory flow assessment.
• DPI not recommended under age 5 (and often under 7): Inspiratory flow may be insufficient, and the required coordination is too advanced.

Nebulizers with face masks remain the most reliable delivery system during acute exacerbations in children under 3, and are often used in emergency departments regardless of age because the child need not cooperate with specific technique.

Elderly patients

Elderly patients present three main challenges for inhaler technique:

1. Reduced grip strength and arthritis — pressing the MDI canister can be physically difficult. Breath-activated MDIs (autoinhalers, which fire when the patient inhales) and spacers can help by reducing the force required.
2. Reduced inspiratory flow — affects DPI delivery; consider switching to MDI + spacer or nebulizer.
3. Cognitive impairment — reinforced teaching at every visit; written step-by-step instructions; caregiver involvement.

Pregnancy

Inhaled medications during pregnancy follow the same technique principles. SABA (albuterol) and ICS are generally considered safe during pregnancy and are recommended over systemic corticosteroids when possible, because systemic exposure is minimized with inhaled delivery. Uncontrolled asthma during pregnancy carries greater fetal risk than controlled asthma on medication. See the asthma nursing guide for more on asthma in pregnancy.

Monitoring response to inhaled medications

Assessing effectiveness is a standard nursing intervention after bronchodilator administration. Key monitoring parameters:

Pre-administration assessment:

• Respiratory rate, work of breathing (accessory muscle use, nasal flaring, retractions), breath sounds (wheeze, decreased aeration)
• SpO2 on current oxygen (see the oxygen therapy nursing guide for SpO2 targets by condition)
• Peak flow reading (if applicable)
• Patient’s subjective dyspnea rating
• Heart rate baseline (bronchodilators can cause tachycardia)

Post-administration reassessment (typically 15–30 minutes for SABA):

• Repeat auscultation — wheeze reduction or clearing indicates bronchodilation
• Repeat peak flow — improvement toward green zone is the target
• SpO2 — may improve as V/Q mismatch resolves (note: initial SpO2 can drop slightly as bronchodilation redistributes blood flow to previously underventilated areas)
• Heart rate — tachycardia and tremor are expected adverse effects of beta-agonists; report sustained HR greater than 110 bpm or symptomatic palpitations
• Patient symptom report — subjective improvement in ease of breathing is clinically meaningful

Document pre- and post-treatment values for every bronchodilator administration. Failure to improve after two SABA treatments is a significant finding requiring immediate provider notification and consideration of escalation to systemic therapy or higher-level care. For escalation in respiratory failure, see the acute respiratory failure nursing guide.

Medication administration context

Inhaled medications are subject to the same rights of medication administration as oral and IV drugs. Before administering any inhaled medication — whether MDI, DPI, SMI, or nebulizer — verify the five rights and complete a pre-administration assessment. For the foundational framework, see the medication rights nursing guide and safe medication administration guide.

Specific inhaler administration checks:

• Verify that the inhaler or nebulizer solution matches the medication administration record (name, dose, route, frequency)
• Check expiration date
• Confirm dose counter (MDI) or verify correct number of doses remain
• For nebulized solutions: verify concentration and volume; check for particulate matter or discoloration

NCLEX tips

1. MDI technique: slow and steady. The most tested MDI error is inhaling too fast. When answering NCLEX questions about technique correction, “inhale slowly over 4–5 seconds” is almost always the right answer.

2. DPI is the opposite: fast and forceful. If a question describes a patient who was told to “inhale slowly” through a DPI, that is the error — correct instruction is a forceful quick breath.

3. Spacer for ICS = mandatory. NCLEX will present a scenario where a patient is using fluticasone MDI without a spacer. The nurse should instruct the patient to add a spacer and rinse their mouth after use.

4. Rinse after ICS, always. The most common ICS complication on NCLEX is oropharyngeal candidiasis. The prevention: rinse mouth and gargle, then spit.

5. Bronchodilator before corticosteroid. If both are ordered at the same time, give SABA first to open airways, then ICS. Sequence is not interchangeable.

6. Do NOT shake a DPI. On NCLEX, if a patient shakes their DPI device, the nurse should intervene and correct this — shaking disrupts the powder dose.

7. Do NOT use a spacer with a DPI. A spacer traps dry powder in the chamber; the drug never reaches the patient.

8. Exhale into the DPI = dose wasted. Moisture from exhalation clumps the powder. The patient must turn away from the device before exhaling.

9. Nebulizer mouthpiece over mask for adults. NCLEX may ask which is preferred for maximum drug delivery — mouthpiece delivers more drug to the lungs than a face mask in cooperative adults.

10. Upright for nebulizer. Position the patient sitting upright, not supine, for all nebulizer treatments.

11. Peak flow green zone = ≥80% personal best. Yellow zone = 50–79%. Red zone = below 50%. The cutoffs must be memorized.

12. SABA more than 2x/week = poor control. Using albuterol for symptoms more than twice per week (not counting pre-exercise use) is a signal to escalate controller therapy — not a sign that the patient is managing well.

13. Float test is outdated. If a question asks how to check MDI fullness and the float test is an option alongside the dose counter, the dose counter is correct. The float test can damage the device.

14. LABA monotherapy in asthma is contraindicated. LABAs must always be paired with ICS in asthma. A LABA ordered without ICS for an asthma patient should prompt the nurse to clarify the order.

15. Do not leave the mouthpiece cap on. Sounds obvious, but it appears on NCLEX as a teaching scenario — a patient reports “pressing the inhaler but not hearing the medication” or “not feeling the spray.” The nurse assesses for cap-on as the first intervention.

16. Cold MDI = reduced dose. A patient who stores their inhaler in a cold car may report it “not working.” Warm the canister before use.

17. Continuous albuterol nebulization requires cardiac monitoring. Tachycardia and hypokalemia are significant risks; monitor ECG and serum potassium in continuous bronchodilator therapy.

Summary

Inhaled medication delivery depends on matching the correct device to the patient, teaching proper technique, and monitoring response. MDIs require slow inhalation and coordination — a spacer solves both problems and is required for ICS in all patients. DPIs require fast, forceful inhalation with no spacer and no moisture. Nebulizers require no special technique and are the best option for acute exacerbations, infants, and patients who cannot use handheld devices. Sequence bronchodilator before corticosteroid. Rinse the mouth after every ICS dose. Monitor peak flow and SABA use frequency to assess control over time.

For the clinical contexts where these skills apply most directly, see the asthma nursing guide, the COPD nursing guide, and the cystic fibrosis nursing guide.